Human T-cell receptors have been defined on inducer, suppressor, and class I and class II specific cytotoxic T lymphocytes as 90 kilodalton T3-associated clonotypic molecules. These are comprised of one 49 to 51-kilodalton alpha and one 43 kilodalton beta subunit, both disulfide linked. Peptide map analysis studies suggested that each subunit is comprised of constant and variable domains. Moreover, the precise molecular basis for this variability in the beta subunit has now been defined by DNA cloning studies, showing that similar to immunoglobulin heavy chain, specific V, D, J, and C segments fuse to form an active Ti gene. This process occurs in the thymus at an early stage of intrathymic ontogeny (stage II). However, surface expression of the T3-Ti complex is restricted to a minor population of thymic lymphocytes (stage III). The ability to identify variable region genes encoding the Ti beta subunit of the T-cell receptor (and shortly the Ti alpha subunit) makes possible, for the first time, analysis of human T-cell malignancies at the clonal level. Thus, it is now feasible to question the extent of clonal variability of tumors within and among clinical types by examining the V genes which are rearranged to form one of their active Ti subunits. This can be related to V gene utilization by """"""""physiologic"""""""" T-cell and thymocyte populations. Our research will include: (1) cloning and sequencing Ti beta V genes from a variety of T-cell malignancies and performing frequency analysis of utilization of these V genes within human thymus and peripheral T-cell compartments; (2) examining the relationship of V genes employed by T-cell acute lymphoblastic leukemias, lymphoblastic lymphomas, and Sezary syndrome to determine whether there is restriction to a single clinical type of malignancy; (3) producing monocloncal antibodies against synthetic peptides corresponding to V gene sequences utilized by several of these tumor populations for direct tissue distribution analysis; and (4) determining whether restriction analysis of DNA from T-cell malignancies with Ti beta probes will be of diagnostic utility. An analogous set of experiments will be performed with the Ti alpha probe as soon as it is available. (AG)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA040134-03
Application #
3179679
Study Section
Experimental Immunology Study Section (EI)
Project Start
1985-08-01
Project End
1988-07-31
Budget Start
1987-08-01
Budget End
1988-07-31
Support Year
3
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Diamond, D J; Nelson, F B; Reinherz, E L (1989) Lineage-specific expression of a T cell receptor variable gene promoter controlled by upstream sequences. J Exp Med 169:1213-31
Alcover, A; Alberini, C; Acuto, O et al. (1988) Interdependence of CD3-Ti and CD2 activation pathways in human T lymphocytes. EMBO J 7:1973-7
Moingeon, P; Alcover, A; Clayton, L K et al. (1988) Expression of a functional CD3-Ti antigen/MHC receptor in the absence of surface CD2. Analysis with clonal Jurkat cell mutants. J Exp Med 168:2077-90
Royer, H D; Reinherz, E L (1987) T lymphocytes: ontogeny, function, and relevance to clinical disorders. N Engl J Med 317:1136-42
Ramarli, D; Fox, D A; Reinherz, E L (1987) Selective inhibition of interleukin 2 gene function following thymocyte antigen/major histocompatibility complex receptor crosslinking: possible thymic selection mechanism. Proc Natl Acad Sci U S A 84:8598-602
Royer, H D; Reinherz, E L (1987) Multiple nuclear proteins bind upstream sequences in the promotor region of a T-cell receptor beta-chain variable-region gene: evidence for tissue specificity. Proc Natl Acad Sci U S A 84:232-6
Alcover, A; Ramarli, D; Richardson, N E et al. (1987) Functional and molecular aspects of human T lymphocyte activation via T3-Ti and T11 pathways. Immunol Rev 95:5-36
Milanese, C; Richardson, N E; Reinherz, E L (1986) Identification of a T helper cell-derived lymphokine that activates resting T lymphocytes. Science 231:1118-22
Siliciano, R F; Hemesath, T J; Pratt, J C et al. (1986) Direct evidence for the existence of nominal antigen binding sites on T cell surface Ti alpha-beta heterodimers of MHC-restricted T cell clones. Cell 47:161-71
Ramarli, D; Fox, D A; Milanese, C et al. (1986) Selective inhibition of interleukin 2 gene function following thymocyte antigen/major histocompatibility complex receptor crosslinking: possible thymic selection mechanism. Proc Natl Acad Sci U S A 83:7008-12

Showing the most recent 10 out of 11 publications